NO20004961L - Nye lokale anestesiforbindelser og anvendelser - Google Patents
Nye lokale anestesiforbindelser og anvendelserInfo
- Publication number
- NO20004961L NO20004961L NO20004961A NO20004961A NO20004961L NO 20004961 L NO20004961 L NO 20004961L NO 20004961 A NO20004961 A NO 20004961A NO 20004961 A NO20004961 A NO 20004961A NO 20004961 L NO20004961 L NO 20004961L
- Authority
- NO
- Norway
- Prior art keywords
- compounds
- applications
- local anesthetic
- new local
- anesthetic compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C233/04—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms not being part of nitro or nitroso groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Anesthesiology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8053198P | 1998-04-03 | 1998-04-03 | |
US12207599P | 1999-03-01 | 1999-03-01 | |
PCT/US1999/007263 WO1999051565A1 (en) | 1998-04-03 | 1999-04-02 | Novel local anesthetic compounds and uses |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20004961L true NO20004961L (no) | 2000-10-02 |
NO20004961D0 NO20004961D0 (no) | 2000-10-02 |
Family
ID=26763633
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20004961A NO20004961D0 (no) | 1998-04-03 | 2000-10-02 | Nye lokale anestesiforbindelser og anvendelser |
Country Status (16)
Country | Link |
---|---|
US (3) | US6337423B1 (hu) |
EP (1) | EP1066245A4 (hu) |
JP (1) | JP2002510669A (hu) |
KR (1) | KR20010034737A (hu) |
CN (1) | CN1295558A (hu) |
AR (1) | AR014809A1 (hu) |
AU (1) | AU3464999A (hu) |
BR (1) | BR9909377A (hu) |
CA (1) | CA2315946A1 (hu) |
CO (1) | CO5040088A1 (hu) |
HU (1) | HUP0102831A2 (hu) |
IL (1) | IL137411A0 (hu) |
NO (1) | NO20004961D0 (hu) |
PE (1) | PE20000354A1 (hu) |
PL (1) | PL342991A1 (hu) |
WO (1) | WO1999051565A1 (hu) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR014809A1 (es) * | 1998-04-03 | 2001-03-28 | Advanced Medicine Inc | Compuestos multiligazon, composicion farmaceutica, metodo para prepara dichos compuestos y uso de dichos compuestos para preparar medicamentos |
US6462034B1 (en) | 1998-04-03 | 2002-10-08 | Theravance, Inc. | Local anesthetic compounds and uses |
EP1216243A1 (en) | 1999-10-01 | 2002-06-26 | Advanced Medicine, Inc. | Quinazolinones and analogues and their use as local anesthetics |
WO2001028550A1 (en) * | 1999-10-15 | 2001-04-26 | Mayo Foundation For Medical Education And Research | Topical anesthetics useful for treating cancer, autoimmune diseases and ischemia |
US20030124174A1 (en) * | 2001-10-25 | 2003-07-03 | Endo Pharmaceuticals, Inc | Method for treating non-neuropathic pain |
DE10161644A1 (de) * | 2001-12-14 | 2003-06-26 | Gruenenthal Gmbh | N,N'-disubstituierte Piperazin-Verbindungen |
US20050112183A1 (en) * | 2003-11-25 | 2005-05-26 | Galer Bradley S. | Compositions and methods for treating neuropathic sensory loss |
US7666914B2 (en) * | 2004-06-03 | 2010-02-23 | Richlin David M | Topical preparation and method for transdermal delivery and localization of therapeutic agents |
CA2628312A1 (en) * | 2005-11-02 | 2007-05-18 | Icagen, Inc. | Inhibitors of ion channels |
TW200804288A (en) | 2005-12-12 | 2008-01-16 | Astrazeneca Ab | Alkylsulphonamide quinolines |
US20100303753A1 (en) * | 2007-10-19 | 2010-12-02 | Nektar Therapeutics | Oligomer Conjugates of Lidocaine and Its Derivatives |
CA2909752A1 (en) | 2013-04-19 | 2014-10-23 | Astrazeneca Ab | A nk3 receptor antagonist compound (nk3ra) for use in a method for the treatment of polycystic ovary syndrome (pcos) |
EP3077365A1 (en) * | 2013-12-05 | 2016-10-12 | Elex Biotech, LLC | Compounds for treatment of cardiac arrhythmias |
CN105418489A (zh) * | 2016-01-22 | 2016-03-23 | 江苏宝众宝达药业有限公司 | 一种布比卡因的合成方法 |
CN110092731B (zh) * | 2018-01-31 | 2022-03-04 | 四川大学华西医院 | 长链胺取代的二甲基苯铵类化合物、制备、自组装结构及用途 |
CN110156665B (zh) * | 2018-02-11 | 2020-07-14 | 四川大学华西医院 | 一种季铵盐类化合物及其制备方法与用途 |
CN108514589A (zh) * | 2018-06-28 | 2018-09-11 | 河南科技大学第附属医院 | 一种用于局部麻醉的中药麻醉剂 |
EP3919476A4 (en) * | 2019-02-01 | 2022-11-23 | West China Hospital, Sichuan University | QUATERNARY AMMONIUM SALT COMPOUND, METHOD FOR PREPARATION AND USE |
CN112574098B (zh) * | 2019-09-30 | 2022-06-07 | 四川大学华西医院 | 一种酰胺化合物及其制备方法和用途 |
TWI794742B (zh) | 2020-02-18 | 2023-03-01 | 美商基利科學股份有限公司 | 抗病毒化合物 |
CN114075184B (zh) * | 2020-08-17 | 2023-05-05 | 四川大学华西医院 | 一种用于麻醉的季铵盐类化合物及其制备方法和用途 |
CN111909039A (zh) * | 2020-09-07 | 2020-11-10 | 江苏湘园化工有限公司 | 一种高位阻效应的脂肪族二元仲胺的制备方法 |
EP4323362A1 (en) | 2021-04-16 | 2024-02-21 | Gilead Sciences, Inc. | Methods of preparing carbanucleosides using amides |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB692332A (en) * | 1950-07-18 | 1953-06-03 | Geigy Ag J R | Improvements relating to quaternary ammonium compounds, and their uses |
DE1054462B (de) * | 1955-10-27 | 1959-04-09 | Espe Fabrik Pharm Praeparate G | Verfahren zur Herstellung von lokalanaesthetisch wirksamen Polyaminoacetaniliden |
DE1056619B (de) * | 1956-11-29 | 1959-05-06 | Bayer Ag | Verfahren zur Herstellung von 4-Nitro-diarylaminen |
DE1204226B (de) | 1963-12-10 | 1965-11-04 | Boehringer Sohn Ingelheim | Verfahren zur Herstellung von bisquaternaeren Zinnkomplexsalzen |
NL137318C (hu) | 1964-06-09 | |||
GB1124837A (en) | 1966-06-03 | 1968-08-21 | Wyeth John & Brother Ltd | Substituted anilides |
US3898070A (en) | 1971-07-29 | 1975-08-05 | Ciba Geigy Corp | Chelates for the control of metal-deficiency-phenomena in biological systems |
US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
JPS52139060A (en) * | 1976-05-13 | 1977-11-19 | Nippon Soda Co Ltd | Imidazorium halides their preparation and fungicides for agriculture and horticulture |
GB1574019A (en) * | 1977-01-14 | 1980-09-03 | Joullie International Sa | Therapeutically useful 3,4,5-trimethoxybenzene derivatives |
US4169106A (en) | 1977-09-30 | 1979-09-25 | Cooper Laboratories, Inc. | Antiarrhythmic N,N'-bis(phenylcarbamoylalkyl)amidines |
US4326525A (en) | 1980-10-14 | 1982-04-27 | Alza Corporation | Osmotic device that improves delivery properties of agent in situ |
US4597903A (en) | 1984-08-21 | 1986-07-01 | University Of Maryland | Process for the direct preparation of N,N-disubstituted derivatives for 4,13-diaza-18-crown-6 |
GB8514209D0 (en) | 1985-06-05 | 1985-07-10 | Unilever Plc | Catalyst additives |
US5023252A (en) | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
US4992445A (en) | 1987-06-12 | 1991-02-12 | American Cyanamid Co. | Transdermal delivery of pharmaceuticals |
US5719197A (en) | 1988-03-04 | 1998-02-17 | Noven Pharmaceuticals, Inc. | Compositions and methods for topical administration of pharmaceutically active agents |
US5134232A (en) | 1988-11-14 | 1992-07-28 | The Regents Of The University Of California | Fluorescent indicator dyes for alkali metal cations |
JP2722250B2 (ja) | 1989-05-30 | 1998-03-04 | 興和株式会社 | 新規なジアミン化合物及びこれを含有する脳機能障害改善剤 |
US4948906A (en) | 1990-02-16 | 1990-08-14 | Ethyl Corporation | Trimethylaluminum process |
CA2036781A1 (en) | 1990-02-22 | 1991-08-23 | Fujio Antoku | Triamine derivatives and their acid-addition salts |
US5405975A (en) * | 1993-03-29 | 1995-04-11 | Molecular Probes, Inc. | Fluorescent ion-selective diaryldiaza crown ether conjugates |
KR100246083B1 (ko) | 1991-02-08 | 2000-03-15 | 버틀러 그레고리 비. | 신경전달물질의 방출조절물질인 치환 구아니딘류 및 그것의 유도체와 그들을 함유하는 약학 조성물 |
US5352705A (en) | 1992-06-26 | 1994-10-04 | Merck & Co., Inc. | Inhibitors of farnesyl protein transferase |
CA2116867C (en) | 1992-07-03 | 2004-04-27 | The Green Cross Corporation | Novel chelating agent, complex compound of said chelating agent and metallic atom, and diagnostic agent comprising same |
EP0582164B1 (en) | 1992-07-31 | 1998-12-23 | Bristol-Myers Squibb Company | Adenosine re-uptake inhibiting derivatives of diphenyl oxazoles, thiazoles and imidazoles |
AU2124197A (en) | 1996-02-13 | 1997-09-02 | Shaman Pharmaceuticals, Inc. | Aniline derivatives having antihyperglycemic activity |
US5731438A (en) * | 1996-08-01 | 1998-03-24 | Isis Pharmaceuticals, Inc. | N-(aminoalkyl)-and/or N-(amidoalkyl)-dinitrogen heterocycles |
AR014809A1 (es) * | 1998-04-03 | 2001-03-28 | Advanced Medicine Inc | Compuestos multiligazon, composicion farmaceutica, metodo para prepara dichos compuestos y uso de dichos compuestos para preparar medicamentos |
-
1999
- 1999-03-31 AR ARP990101483A patent/AR014809A1/es unknown
- 1999-03-31 CO CO99019383A patent/CO5040088A1/es unknown
- 1999-03-31 PE PE1999000262A patent/PE20000354A1/es not_active Application Discontinuation
- 1999-04-02 IL IL13741199A patent/IL137411A0/xx unknown
- 1999-04-02 US US09/285,054 patent/US6337423B1/en not_active Expired - Lifetime
- 1999-04-02 CN CN99804507A patent/CN1295558A/zh active Pending
- 1999-04-02 CA CA002315946A patent/CA2315946A1/en not_active Abandoned
- 1999-04-02 JP JP2000542287A patent/JP2002510669A/ja not_active Withdrawn
- 1999-04-02 PL PL99342991A patent/PL342991A1/xx unknown
- 1999-04-02 EP EP99916299A patent/EP1066245A4/en not_active Withdrawn
- 1999-04-02 AU AU34649/99A patent/AU3464999A/en not_active Abandoned
- 1999-04-02 HU HU0102831A patent/HUP0102831A2/hu unknown
- 1999-04-02 KR KR1020007011022A patent/KR20010034737A/ko not_active Application Discontinuation
- 1999-04-02 BR BR9909377-4A patent/BR9909377A/pt not_active Application Discontinuation
- 1999-04-02 WO PCT/US1999/007263 patent/WO1999051565A1/en not_active Application Discontinuation
- 1999-04-02 US US09/647,802 patent/US6576791B1/en not_active Expired - Lifetime
-
2000
- 2000-10-02 NO NO20004961A patent/NO20004961D0/no not_active Application Discontinuation
- 2000-10-17 US US09/690,019 patent/US6495681B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
WO1999051565A9 (en) | 1999-12-02 |
US6576791B1 (en) | 2003-06-10 |
CA2315946A1 (en) | 1999-10-14 |
US6337423B1 (en) | 2002-01-08 |
PE20000354A1 (es) | 2000-05-20 |
HUP0102831A2 (hu) | 2001-12-28 |
JP2002510669A (ja) | 2002-04-09 |
AR014809A1 (es) | 2001-03-28 |
WO1999051565A1 (en) | 1999-10-14 |
BR9909377A (pt) | 2000-12-05 |
KR20010034737A (ko) | 2001-04-25 |
CN1295558A (zh) | 2001-05-16 |
AU3464999A (en) | 1999-10-25 |
CO5040088A1 (es) | 2001-05-29 |
EP1066245A4 (en) | 2001-01-24 |
IL137411A0 (en) | 2001-07-24 |
NO20004961D0 (no) | 2000-10-02 |
EP1066245A1 (en) | 2001-01-10 |
PL342991A1 (en) | 2001-07-16 |
US6495681B1 (en) | 2002-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20004961L (no) | Nye lokale anestesiforbindelser og anvendelser | |
SE9704546D0 (sv) | Novel compounds | |
DK0915974T3 (da) | Modificerede tie-2 receptor-ligander | |
CY1108897T1 (el) | Μοριακοι μιμητες των επιτοπων του μηνιγγιοκοκκου β | |
FI960888A0 (fi) | Protokadheriiniproteiineja ja niiden käyttö | |
BR9910089A (pt) | Composições e antìgenos de neisseria meningitidis | |
CA2413190A1 (en) | Methods for treating rheumatic diseases using a soluble ctla4 molecule | |
EE200000320A (et) | Uudsed ühendid | |
DE69940080D1 (de) | Neue Verwendung von Glutamat-Antagonisten zur Behandlung von Krebs | |
ID28003A (id) | Turunan-turunan adamantana | |
ATE215094T1 (de) | Komplement verwandte proteine und kohlenhydrate enthaltende zusammensetzungen und methoden zur herstellung und verwendung dieser zusammensetzungen | |
ATE245993T1 (de) | Allosterische modulatoren des nmda-rezeptors | |
ATE370967T1 (de) | Polyspezifische bindemoleküle und deren verwendung | |
ES2186870T3 (es) | Complejo de factor viii estable, procedimiento para su preparacion asi como preparaciones farmaceuticas del mismo. | |
BG102215A (en) | Compounds and pharmaceutical compositions containing them | |
PL316442A1 (en) | Derivatives of 5h-indene [1,2-b] piperazino-2,3-dione, method of obtaining them and drugs containing such derivatives | |
MY118828A (en) | Substituted amino compounds and their use as substances having an analgesic effect | |
TR199700834T1 (xx) | 1-Aril-2-Akilamino ethan bile�ikleri ve bunlar�n n�rokinin olarak �zellikle n�rokinin 1 has�mlar� olarak kullan�mlar�. | |
Hong et al. | Bis (diphenylphosphino) acetylene as bifunctional ligand in dicobalt carbonyl complexes | |
DE69734096D1 (de) | Rezeptor des ob-proteins und verwandte zusammensetzungen und verfahren | |
DK0793721T3 (da) | Peptider, der er i stand til at binde sig til GAP-proteinets SH3-domæne, nukleotidsekvenser, der koder derfor, fremstilling og anvendelse deraf | |
BR0014472A (pt) | Processo e dispositivo para a preparação contìnua de uma mistura de polìmeros termoplástica e sua aplicação | |
BG103872A (en) | Glycoconjugates of 20(s)-camptotecin | |
WO1993015203A3 (en) | Polypeptides with fibronectin binding sites as modulators for matrix assembly | |
ID21353A (id) | Senyawa bi-aromatik yang terikat melalui radikal heteroetilena, serta komposisi farmasi dan kosmetik yang mengandungnya |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |